Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
HAART is neuroprophylactic in HIV-1 infection.
J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):380-5. Unique Identifier : AIDSLINE MED/20322599 von Giesen HJ; Hefter H; Jablonowski H; Arendt G; Department of Neurology, Heinrich Heine University, Dusseldorf,; Germany. giesenhj@uni-duesseldorf.de
Abstract:
BACKGROUND: To find out about the prophylactic value of antiretroviral therapy on HIV-1-associated subclinical and clinical psychomotor slowing as one marker of HIV-1-associated CNS disease. METHODS: Prospective study with regular clinical and neurophysiologic examination every three months of 1482 consecutive HIV-1-seropositive and AIDS patients seen at our department till June 30, 1999. RESULTS: Antiretroviral therapy has a significant prophylactic value over an individual observation period of ten years with regard to the first, potentially transient manifestation of HIV-1-associated subclinical psychomotor slowing and with regard to the clinical manifestation of motor signs. However, a subgroup of patients is characterized through a second, more sustained manifestation of subclinical psychomotor slowing which cannot be prevented by any type of currently available antiretroviral therapy. CONCLUSIONS: These findings suggest the existence of different pathomechanisms underlying HIV-1-associated brain disease which may in part be effectively prevented, but which in part also escape all antiretroviral treatment strategies in use today.
Keywords: JOURNAL ARTICLE Anti-HIV Agents/*THERAPEUTIC USE Drug Therapy, Combination Female Human HIV Infections/COMPLICATIONS/*DRUG THERAPY/PHYSIOPATHOLOGY HIV-1/*PHYSIOLOGY Male Prospective Studies Psychomotor Disorders/ETIOLOGY/*PREVENTION & CONTROL/ PHYSIOPATHOLOGY 001030
A00A1070
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from
Elton John AIDS Foundation,
the National Library of Medicine,
and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.